SHREE GANESH REMEDIES
Back to Balance Sheet
|
SHREE GANESH REMEDIES Last 5 Year Total Liabilities History
[Consolidated]
| Mar2025 | Mar2024 | Mar2020 | Mar2019 | |
|---|---|---|---|---|
| Total Liabilities | ₹200 Cr | ₹178 Cr | ₹55 Cr | ₹41 Cr |
What is the latest Total Liabilities ratio of SHREE GANESH REMEDIES ?
| Year | Total Liabilities |
|---|---|
| Mar2025 | ₹200 Cr |
| Mar2024 | ₹178 Cr |
| Mar2020 | ₹55 Cr |
| Mar2019 | ₹41 Cr |
How is Total Liabilities of SHREE GANESH REMEDIES Trending?
| Years | Total Liabilities | % Change | |
|---|---|---|---|
| Mar2025 | ₹200 Cr | 12.22 | |
| Mar2024 | ₹178 Cr | 222.38 | |
| Mar2020 | ₹55 Cr | 33.71 | |
| Mar2019 | ₹41 Cr | - | |
Compare Total Liabilities of peers of SHREE GANESH REMEDIES
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| SHREE GANESH REMEDIES | ₹650.7 Cr | 2.6% | 4.1% | -31.3% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹437,879.0 Cr | 1.5% | 6.9% | 13.1% | Stock Analytics | |
| DIVIS LABORATORIES | ₹166,620.0 Cr | -0.8% | 1.7% | 14% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹150,431.0 Cr | 3.2% | 9% | 44.8% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹110,070.0 Cr | 1.1% | 5% | 16.4% | Stock Analytics | |
| CIPLA | ₹107,051.0 Cr | 0.3% | -1.3% | -9% | Stock Analytics | |
SHREE GANESH REMEDIES Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| SHREE GANESH REMEDIES | 2.6% |
4.1% |
-31.3% |
| SENSEX | -5% |
-9.6% |
3.1% |
You may also like the below Video Courses